Pfizer’s Financial Supernova and the Art of Really Big Lies
The manufactured COVID pandemic has been a proverbial golden egg-laying goose for Pfizer. Its annual revenue is expected to reach $ 101.3 billion in 2022,1 thanks to its COVID jab, which doesn’t prevent infection or spread, and Paxlovid, an ineffective and dangerous COVID antiviral that causes rebound. It would be comical if it weren’t so… Read More »